In this study, we investigated the molecular mechanisms of toxicity of 1-methyl-4-phenylpyridinium (MPP Parkinson's disease (PD) 1 is characterized by mitochondrial complex I defects, elevated iron levels in brain tissue, tetrahydrobiopterin (BH 4 ) and dopamine deficiencies, and ␣-synuclein accumulation in Lewy body aggregates (1-4). The exact molecular mechanisms leading to the pathophysiology of PD are not well understood. 1-Methyl-4-phenylpyridinium ion (MPP ϩ ), a mitochondrial complex I inhibitor, produces Parkinson-like symptoms in humans and laboratory animals, and has been used to investigate the mechanism of pathogenesis of PD (5, 6). MPP ϩ is the ultimate metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a contaminant found in illicit narcotics (7, 8) . MPP ϩ is taken up into dopaminergic neurons via the dopamine transporter and accumulates into mitochondria, where it inhibits complex I activity. Although the mechanism of MPP ϩ -induced neurotoxicity is not fully understood, there is increasing evidence supporting the involvement of reactive oxygen species (ROS) and reactive nitrogen species (RNS) (1, 9).
Parkinson's disease (PD) 1 is characterized by mitochondrial complex I defects, elevated iron levels in brain tissue, tetrahydrobiopterin (BH 4 ) and dopamine deficiencies, and ␣-synuclein accumulation in Lewy body aggregates (1) (2) (3) (4) . The exact molecular mechanisms leading to the pathophysiology of PD are not well understood. 1-Methyl-4-phenylpyridinium ion (MPP ϩ ), a mitochondrial complex I inhibitor, produces Parkinson-like symptoms in humans and laboratory animals, and has been used to investigate the mechanism of pathogenesis of PD (5, 6) . MPP ϩ is the ultimate metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a contaminant found in illicit narcotics (7, 8) . MPP ϩ is taken up into dopaminergic neurons via the dopamine transporter and accumulates into mitochondria, where it inhibits complex I activity. Although the mechanism of MPP ϩ -induced neurotoxicity is not fully understood, there is increasing evidence supporting the involvement of reactive oxygen species (ROS) and reactive nitrogen species (RNS) (1, 9) .
Previous studies using the neuronal nitric-oxide synthase (nNOS) knockout mice implicate nitric oxide ( ⅐ NO) and peroxynitrite (ONOO Ϫ ) in MPP ϩ -induced neurodegeneration (10). However, therapeutic intervention studies with nitric-oxide synthase (NOS) inhibitors in MPTP-treated mice demonstrated the opposite result, i.e. the attenuation of ⅐ NO was more deleterious than protective (11) (12) (13) (14) . Decreased formation of ⅐ NOderived metabolites (nitrite and nitrate) in cerebrospinal fluids was observed in PD (15) . Furthermore, low levels of tetrahydrobiopterin (BH 4 ) were detected during the onset and progression of PD (2, 16, 17) . BH 4 is a critical cofactor for NOS activity (18, 19) . Evidence indicates that BH 4 , by acting as a "redox switch," plays a critical role in increasing not only the rate of ⅐ NO generation by NOS, but also in controlling the formation of superoxide and hydrogen peroxide (20 -22) . Pharmacological manipulation of BH 4 has been suggested as a therapeutic strategy to modulate ⅐ NO and superoxide generation in neuronal cells and endothelial cells (23) (24) (25) (26) (27) . De novo biosynthesis of BH 4 is catalyzed by guanosine 5Ј-triphosphate cyclohydrolase I (GT-PCH I) (28, 29) . Mammalian cells can also generate BH 4 by another pathway wherein sepiapterin is converted to BH 4 by sepiapterin reductase and dihydrofolate reductase (28, 29) . Intracellular BH 4 levels are inhibited by 2,4-diamino-6-hydroxypyrimidine (DAHP), an inhibitor of GTPCH I, and enhanced by sepiapterin treatment of cells. However, modulation of BH 4 synthesis has yielded opposing results in cardiovascular and cerebrovascular systems (23) (24) (25) (26) (27) . Blockade of BH 4 biosynthesis in animals protects against postischemic neuronal injury (23), whereas increased intracellular BH 4 from supplementation with sepiapterin enhanced endothelial function thereby inhibiting postischemic heart injury (24, 25) . Thus, the exact relationship between ⅐ NO, BH 4 , and cytotoxicity/cytoprotection still remains ambiguous and further mechanistic studies clarifying the role of BH 4 in oxidative injury in cellular systems deserve additional consideration.
Oxidant-induced iron signaling and the subsequent occurrence of free radical-mediated oxidative damage are becoming increasingly understood as playing highly significant roles in neurodegeneration (30 -32) . Mitochondrial toxins that stimulate O 2 . and H 2 O 2 cause excessive accumulation of cellular iron (33, 34) . Iron has been shown to be abundantly present in the substantia nigra, whose levels have been reported to be consistently enhanced in the PD brain (4) . A major pathway by which neuronal cells acquire iron is via the transferrin receptor (TfR), which facilitates the uptake of iron-loaded transferrin (35) . In a previous study, we showed that MPP ϩ up-regulates TfR expression and iron uptake, leading to oxidative stress and apoptosis in neuronal cells (36) .
Recently, we and others reported that ⅐ NO is critical to regulating oxidant-induced intracellular iron uptake (37) (38) (39) . In this study, we seek to understand better the interaction between ⅐ NO, BH 4 , iron, and neuronal apoptosis in response to MPP ϩ treatment. For these studies, we used cerebellar granule neurons (CGNs) for the following reasons: (i) CGNs express an organic cation transporter 3 that makes them vulnerable to MPP ϩ toxicity, much like neurons expressing the dopamine transporter (40) ; (ii) CGNs express a high level of nNOS that makes it possible to test the "uncoupling" mechanism of nNOS influenced by BH 4 modulation; and (iii) MPP ϩ induces an iron-dependent apoptosis in CGNs (36) . Results indicate that MPP ϩ -induced BH 4 depletion is dependent on TfR-iron signaling and is caused by MPP ϩ -dependent TfR up-regulation, which ultimately results in nNOS uncoupling (i.e. switching from ⅐ NO to superoxide generation). Increasing the intracellular BH 4 levels by sepiapterin supplementation partially restored mitochondrial respiratory enzyme activity, restored the nNOS activity ( ⅐ NO generation), inhibited superoxide formation from the uncoupling mechanism, and prevented TfR-dependent iron accumulation and apoptotic cell death. Implications for the role of nNOS in iron signaling in PD are discussed.
EXPERIMENTAL PROCEDURES
Materials-1-Methyl-4-phenylpyridinium (MPP ϩ ), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), deferoxamine, and N G -nitro-L-arginine-methyl ester HCl (L-NAME) were purchased from Sigma. L-Sepiapterin, DAHP, N-acetylserotonin (NAS), and N Gmonomethyl-L-arginine monoacetate (L-NMMA) were bought from Alexis Biochemicals (San Diego, CA). 7-Nitroindazole was purchased from Calbiochem-Novabiochem Corp. (La Jolla, CA). The fluorogenic substrates for proteasome assay Boc-VLK-AMC (Boc-Val-Leu-Lys-7-amido-4-methylcoumarin) was bought from Sigma, and N-Suc-LLVY-AMC (N-succinyl-Leu-Leu-Val-Tyr-7-amido-4-methylcoumarin) was bought from Biomol Research Laboratories, Inc. (Plymouth Meeting, PA). HBED (N,NЈ-bis(2-hydroxybenzyl ethylenediamine-N,NЈ-diacetic acid) was a kind gift from Dr. Cherakuri Muralikrishna (National Cancer Institute, Bethesda, MD.). Carboxy-2Ј,7Ј-dichlorodihydrofluorescein diacetate (carboxy-H 2 DCFDA) and dihydroethidium (hydroethidine or DHE) were purchased from Molecular Probes Inc. (Eugene, OR).
QuickPrep micro mRNA purification kit, Ready-to-go You-Prime-FirstStrand Beads, and First-strand cDNA synthesis kit were purchased from Amersham Biosciences. TRIzol reagent was obtained from Invitrogen. The caspase 3 assay kit (colorimetric) was purchased from Sigma. ApoAlert DNA fragmentation assay kit was purchased from Clontech (Palo Alto, CA). Mouse-anti-human TfR antibody was purchased from Zymed Laboratories Inc. (South San Francisco, CA). Mouse anti-rat nNOS protein antibody was purchased from BD Transduction Laboratories (San Diego, CA). Mouse-anti-actin antibody was purchased from Chemicon International Inc. (Temecula, CA). Monoclonal antibody 42/6 against human TfR was a gift from Dr. Ian Trowbridge (Salk Institute, San Diego, CA). 55 Fe (ferric chloride) (1 mCi/100 l) was obtained from PerkinElmer Life Sciences. Rat GTP cyclohydrolase I (GTPCH I) and rat transferrin receptor-specific cDNA primers (shown below) were synthesized by Operon Technologies (Alameda, CA). Other salts and buffers were obtained from the usual commercial sources.
CGN Primary Culture-CGNs were prepared from 6 -8-day-old rat pups of either sex exactly as described previously (41) . Cells were plated at density of 1.4 ϫ 10 6 cells/ml in 12-or 6-well plates coated with poly-D-lysine. For the terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) assay, CGNs were plated at a density of 1 ϫ 10 6 cells/ml. After 24 h, cytosine arabinoside (10 M) was added to the cultures to inhibit glial proliferation. Approximately 5% of the cells present in the cultures are astroglia; a few phase-bright microglia can be seen in each high power field, and the remaining cells are CGNs. CGNs were used for experiments on day 10.
Reverse Transcription-Polymerase Chain Reaction (RT-PCR)-For

RT-PCR of GTPCH I, poly(A)
ϩ mRNA was prepared from either cells or tissues using QuickPrep micro mRNA purification kit and cDNA was synthesized using the You-Prime-First-Strand Beads using oligo(dT) as a primer. The sense and antisense primers for rat GTPCH I were 5Ј-GGA TAC CAG GAG ACC ATC TCA-3Ј and 5Ј-TAG CAT GGT GCT AGT GAC AGT-3Ј, respectively. These primers correspond to the nucleotide positions 422-442 and 773-793, respectively, and size of the expected product was 372 bp. An annealing temperature of 55°C was used, and the cycle was repeated 30 times. For semiquantitative RT-PCR of TfR, total RNA from CGNs was extracted using TRIzol (Invitrogen). Two micrograms of total RNA was reverse transcribed using a first-strand cDNA synthesis kit (Amersham Biosciences) employing random hexamers. For RT-PCR, the number of cycles and the amount of cDNA are optimized to fall into the exponential phase of the polymerase chain reaction. The sense and antisense primers for rat transferrin receptor were 5Ј-AGT TTC CGC CAT CTC AGT C-3Ј and 5Ј-ACG TCC TGC ATT ATC TTC CC-3Ј, respectively. These primers correspond to the nucleotide positions 546 -564 and 1106 -1125, respectively, and size of the expected product was 580 bp. An annealing temperature of 55°C was used, and the cycle was repeated 30 times. All primers were designed employing Genetics Computer Group, Inc. (GCG) software. The PCR products were resolved on 2% agarose gel, and the bands were quantified by densitometry.
MTT Reduction Cytotoxicity Assay-MTT is converted in living cells to formazan, which has a specific absorption maximum at 562 nm. Treatment agents were added directly to the culture media. After treatment, the culture media were removed and cells were washed three times with control salt solution (CSS) (120 mM NaCl, 25 mM HEPES, pH 7.4, 25 mM KCl, 1.8 mM CaCl 2 , 4 mM MgCl 2 , and 15 mM glucose). Cells were incubated in CSS buffer containing 0.25 mg/ml MTT for 2 h at 37°C. CSS buffer was removed, and cells were solubilized and mixed thoroughly in isopropanol, 0.08 N HCl (1:1). The absorption was measured at 562 nm with reference at 630 nm.
Measurement of Caspase-3-like Protease Activity-Caspase-3-like protease activity was assayed according to the protocol from the manufacturer (Caspase 3 Assay Kit, Sigma) with the following modification. CGNs were cultured in 6-well plates and exposed to MPP ϩ on day 10. Pretreatment drugs were added in culture media 2 h before MPP ϩ treatment. After a 24-h incubation, CGNs were washed, scraped, and pelleted with cold PBS. The cell pellet was lysed in 50 l of lysis buffer (50 mM HEPES, pH 7.4, 5 mM CHAPS, and 5 mM DTT). Following homogenization and incubation on ice for 15-20 min, lysates were centrifuged at 16,000 ϫ g at 4°C for 20 min. Aliquots of 40 l of lysate were incubated with 50 l of assay buffer (20 mM HEPES, pH 7.4, 0.1% CHAPS, 5 mM DTT, 2 mM EDTA) and 10 l of caspase-3 substrate (Ac-DEVD-p-nitroaniline, 200 M) at 37°C for 2 h. Protein concentration was determined according to the Lowry method.
Terminal Deoxynucleotidyltransferase-mediated dUTP Nick End Labeling (TUNEL) Staining-CGNs were cultured on chamber slips at a density of 1 ϫ 10 6 cells/ml. Beginning on day 10, the cells were exposed to MPP ϩ for 30 h. Pretreatment drugs were added in culture media 2 h before MPP ϩ treatment. DNA fragmentation of individual cells was detected in situ by TUNEL with ApoAlert DNA fragmentation assay kit (Clontech). Briefly, cells were washed with PBS and fixed in formaldehyde solution (4% in PBS) for 25 min at 4°C. Cells were washed and permeabilized in a solution containing 0.2% Triton X-100 in PBS for 5 min at 4°C, followed by incubation in freshly prepared terminal deoxynucleotidyltransferase incubation buffer for 60 min at 37°C in the dark. Cells were washed with PBS, stained with propidium iodide, mounted in an anti-fade solution, and visualized under a Nikon microscope. Fluorescein-dUTP incorporated into the fragmented nucleotides exhibited green fluorescence at an emission wavelength of 528 nm. All cells stained with propidium iodide exhibited red fluorescence at an emission wavelength of 617 nm. Cells were identified as apoptotic if they showed positive TUNEL staining (yellow color on overlay images). Apoptosis was assessed by counting the number of TUNEL-positive cells in at least three randomly selected fields and expressed as a percentage of the total number of cells counted.
Determination of TfR and nNOS Levels-CGNs were washed with ice-cold PBS and resuspended in 50 l of radioimmune precipitation assay buffer (20 mM Tris-HCl, pH 7.4, 2.5 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 1% SDS, 100 mM NaCl, 100 mM sodium fluoride). To a 10-ml solution of the above, 1 mM sodium vanadate and 1 tablet of protease inhibitor mixture (Roche Applied Science) were added. Cells were homogenized, and the lysate was centrifuged for 10 min at 12,000 ϫ g at 4°C. Protein was determined by the Lowry method, and 20 g was used for the Western blot analysis. Proteins were resolved on 8% SDS-polyacrylamide gels and blotted onto nitrocellulose membranes. Low temperature SDS-PAGE (LT-PAGE) was performed according to a published method (42) . Basically, equal amounts of protein were mixed with Laemmli sample buffer at 4°C. Gel (6%) and buffer were equilibrated at 4°C prior to electrophoresis and the buffer tank placed in 4°C refrigerator during electrophoresis to keep the temperature below 10°C. Subsequent to LT-PAGE, protein was transferred to a nitrocellulose membrane. Membranes were washed with Tris-buffered saline (140 mM NaCl, 50 mM Tris-HCl, pH 7.2) containing 0.1% Tween 20 and 5% skim milk to block nonspecific protein binding. Membranes were incubated with mouse anti-human transferrin receptor monoclonal antibody (Zymed Laboratories Inc. 1 g/ml) or mouse anti-rat neuronal nitric-oxide synthase monoclonal antibody (BD Transduction Laboratories; 1 g/ml) in Tris-buffered saline containing 0.1% Tween 20 for 1.5 h at room temperature. Following washing, the membranes were incubated with horseradish peroxidaseconjugated rabbit anti-mouse IgG (1:5000) for 1.5 h at room temperature. The TfR and nNOS bands were detected using the ECL method (Amersham Biosciences). Subsequently, blots were stripped and reprobed with an antibody against actin.
Measurement of Aconitase Activity-Aconitase activity was measured according to the published method with some modifications (43) . CGNs were washed twice with cold phosphate-buffered saline (PBS), scraped, and centrifuged at 3,000 rpm for 10 min to pellet the cells and homogenized using a 25-gauge syringe needle (10 strokes) with 100 l of lysis buffer (0.2% Triton X-100, 100 M diethylenetriamine pentaacetic acid, and 5 mM citrate in PBS). The lysate was centrifuged at 12,000 rpm for 10 min, aconitase activity was measured in the supernatant, and protein was estimated by the Lowry method. The activity of aconitase was measured in 100 mM Tris-HCl (pH 8.0, 100 l) containing 20 mM DL-trisodium isocitrate. The rate of change of absorbance was followed for 3 min at 240 nm in a UV-visible spectrophotometer (UV-1601PC; Shimadzu Corp.) at room temperature. An extinction coefficient for cis-aconitase of 3.6 mM Ϫ1 cm Ϫ1 at 240 nm was used to calculate the enzyme activity and the values were expressed as micromoles/ min/mg of protein.
Electrophoretic Mobility Shift Assay-IRP/IRE binding was measured by the electrophoretic mobility shift assay.
32 P-Labeled IRE mRNA for the RNA band shift assay was prepared using as a template a 1000-base pair rat L ferritin pseudogene that contains the conserved IRE sequence. The plasmid (p66-L gene) containing this insert (which was generously provided by Dr. Elizabeth Leibold) was linearized with SmaI (Invitrogen) and used for in vitro transcription of IRE mRNA. Transcription was carried out with Sp6 RNA polymerase using a Riboprobe transcription system from Promega.
Measurement of Oxidative Stress-The determination of intracellular oxidant production was based on the oxidation of carboxy-H 2 DCFDA, resulting in the formation of the fluorescent compound carboxy-2Ј,7Ј-dichlorofluorescein (carboxy-DCF). Following treatment of CGNs with MPP ϩ , the medium was aspirated, and cells were washed twice with PBS and incubated in 1 ml of cell culture medium without fetal bovine serum. Carboxy-H 2 DCFDA was added to a final concentration of 10 M and incubated for 20 min. Cells were washed with PBS and maintained in 1 ml of culture medium. Fluorescence was monitored using a Nikon fluorescence microscope with wavelengths of 480/30 nm (excitation) and 535/40 nm (emission). The fluorescence intensity values from three different fields of view were calculated using the Metamorph software.
Hydroethidine (Dihydroethidium) Staining-The redox-sensitive, cell-permeable fluorophore hydroethidine (dihydroethidium, DHE) was used to evaluate the cellular production of superoxide in vivo. Following treatment of CGNs, culture medium was aspirated and cells were washed once with PBS and incubated in a fresh culture medium without fetal bovine serum. DHE (5 M) was added to cells, and the incubation was continued for 20 min. Fluorescence images were obtained using a Nikon fluorescence microscope at excitation and emission wavelengths of 540/25 nm and 605/55 nm, respectively. The fluorescence intensity values from three different fields of view were calculated using the Metamorph software, and the average values presented.
Determination of Tetrahydrobiopterin Levels in CGNs-Tetrahydrobiopterin levels in CGNs were assayed using HPLC with fluorescence detection according to the method reported previously (44) . Cells were washed three times with ice-cold PBS. For assays of total (reduced ϩ oxidized) biopterin, 0.5 ml of ice-cold 0.1 N HCl was added to each well and cells were collected; for assays of oxidized biopterin, 0.5 ml of ice-cold 0.01 N NaOH was added to each well and cells were collected. After sonication for 1 min at 40 watts in ice, the cell suspension was centrifuged for 20 min at 12,000 ϫ g at 4°C. The supernatant (100 l) was assayed for protein concentration by Bradford analysis (Bio-Rad) according to the instructions from the manufacturer. The supernatant (0.3 ml) was mixed with 50 l of iodine solution (2%/1% KI/I 2 in distilled water) for biopterin measurement. The mixture was incubated at room temperature for 1 h in the dark. After incubation, 1 l of 5 N HCl was added only to the mixture for alkaline-oxidized biopterin. Excess iodine was reduced by adding 5 l of 50% ascorbic acid solution. Biopterin levels were analyzed by HPLC (using a C18 reverse-phase column) with a fluorescence detector with excitation at 350 nm and emission at 440 nm using authentic biopterin as standard. The chromatographic mobile phase was 25 mM phosphate buffer, pH 6.4, and was delivered at a flow rate of 0.7 ml/min. The reduced biopterin was determined by subtracting the oxidized biopterin from the total biopterin.
Measurement of Nitrite and Nitrate-Nitrite and nitrate, oxidative metabolites of ⅐ NO, were measured by chemiluminescence according to a modified method (45) . Briefly, after treatment of CGNs, culture medium was aspirated and cells were washed three times with Hanks' buffer (110 mM NaCl, 25 mM KCl, 20 mM HEPES, 5.5 mM glucose, 1.25 mM CaCl 2 , 1 mM MgCl 2 , pH 7.4). Cells were incubated with fresh Hanks' buffer containing 25 M L-arginine. Nitrite/nitrate levels in the incubation buffer were first measured (sample I). Cells were incubated with the buffer for 30 min at 37°C. Samples were analyzed for nitrite/nitrate content (sample II). Nitrite/nitrate present in sample I was subtracted from sample II to correct for the background nitrite/nitrate contamination. Protein concentration in each well was measured according to the Bradford method. For nitrite measurement, a solution containing KI and glacial acetic acid was used. For nitrate and nitrite measurement, a solution containing vanadium and HCl was used. ⅐ NO generated from sodium nitrite and sodium nitrate were used as standards.
Measurement of GTPCH I Activity in CGNs-GTPCH I activity in CGNs was assayed using HPLC with fluorescence detection. Cells were washed three times with ice-cold PBS and collected in 0.5 mM Tris-HCl, pH 7.4, containing protease inhibitor (Roche Applied Science). After sonication for 1 min at 40 watts in ice, the cell suspension was centrifuged for 20 min at 12,000 ϫ g at 4°C. Cell lysate was incubated with 1 mM GTP, 1 mM DTT, 1 mg/ml bovine serum albumin in 0.1 mM Tris-HCl, pH 7.4 for 2 h at 37°C in the dark. The reaction product, dihydroneopterin, was oxidized to neopterin triphosphate using the iodine solution (2%/4% I 2 /KI) for 10 min in the dark. Excess iodine was reduced by ascorbic acid, and the pH was adjusted to alkalinity by adding the 2 M Tris-base. Neopterin triphosphate was dephosphorylated by the alkaline phosphatase (5 units/100 l) at 37°C for 1 h. The reaction was stopped by acidification with 1 M H 3 PO 4 , and the product neopterin was determined by a reverse-phase HPLC (a 5C18 reversephase column) using a fluorescence detector with an excitation wavelength at 350 nm and an emission wavelength at 440 nm using authentic neopterin as standard. The chromatographic mobile phase was 3% acetonitrile in distilled water and delivered at a flow rate of 0.1 ml/min.
Measurement of 55 Fe Uptake in CGNs-CGNs were cultured in 6-well plates and treated with MPP ϩ for desired time points. Ferric chloride (0.2 Ci/ml 55 Fe) was added to the media and incubated for another 4 h at 37°C. After incubation, 200 l of medium was taken to count 55 Fe in media. Cells were washed in cold 1ϫ PBS three times and lysed in 500 l of lysis buffer (1ϫ PBS, 0.1% Triton X-100, and protease inhibitor). After centrifuging at 6000 ϫ g at room temperature for 10 min, 350 l of supernatant was taken to count 55 Fe in cell lysate. Supernatant (50 l) was used to measure protein concentration by the Bradford method.
Proteasome Function Assays-Proteasome function was measured as reported previously (37, 46) . Briefly, cells were lysed in 100 l of ice-cold homogenization buffer (20 mM Tris-HCl, pH 7.4, 0.1 mM EDTA, 2 mM DTT, 5 mM ATP, 20% (v/v) glycerol, and 0.04% (v/v) Nonidet P-40). Lysate (10 l) was taken to measure protein concentration by Bradford method. Lysate (40 l) was incubated at 37°C with the fluorogenic substrate Boc-VLK-AMC (80 M, trypsin-like) or Suc-LLVY-AMC (100 M, chymotrypsin-like) in 500 l of assay buffer (50 mM Tris-HCl, pH 7.4, 2 mM DTT, 5 mM MgCl 2 , and 2 mM ATP) for 30 and 60 min, respectively. Proteolytic activity was measured by monitoring the release of the fluorescent group 7-amido-4-methylocoumarin (AMC) at 380 nm excitation and 460 nm emission wavelengths using a Shimadzu spectrofluorophotometer (RF-5301PC). All readings were standardized using the fluorescence intensity of an equal volume of free AMC solution.
Data Analysis-Statistical significance was obtained using Student's t test employing the Sigmastat software.
RESULTS
MPP
ϩ -induced Iron Signaling in CGNs-Cytosolic aconitase is an indicator of intracellular iron level and oxidant formation and has been shown to play an important role as an iron sensor (47) (48) (49) . CGNs were treated with MPP ϩ (70 M), and the total aconitase activity was measured in whole cell lysates at different time points. As shown in Fig. 1A , a steady decrease in aconitase activity with time was observed. The aconitase activity initially decreased after a 12-h incubation with MPP ϩ , and further decreased with prolonged incubation of 48 h. Inactivation of aconitase by oxidative destruction of the [4Fe-4S] cluster is accompanied by an increase in its mRNA (IRE) binding activity, which is known as the "IRP1 activity" (49) . As shown in Fig. 1B , treatment of cells with 70 M MPP ϩ caused a time-dependent increase in IRP1 activity. At least a 10-fold increase in active IRP1 with respect to total IRP1 (active and inactive) was detected in MPP ϩ -treated CGNs within 12 h (Fig.  1B, left panel) . When lysates were treated with 1% ␤-mercaptoethanol to completely activate IRP1 to the high affinity mRNA-binding form (50) , differences in IRP1 binding to IRE were not observed between control and MPP ϩ -treated cells (Fig. 1B, right panel) . These data suggest that MPP ϩ treatment causes IRP1 activation, likely as a consequence of the inactivation of aconitase.
A result of increased IRP1/IRE binding is stabilization of TfR mRNA leading to increased TfR synthesis. The effects of MPP ϩ treatment on TfR protein and mRNA levels as a function of time were determined. As shown in Fig. 1 (C and D) , MPP ϩ treatment induced the expression of TfR protein and mRNA in CGNs. TfR levels increased in MPP ϩ -treated cells after 12 h and remained elevated up to 48 h. To examine whether increased cellular TfR expression results in increased cellular iron, we measured cellular 55 Fe uptake in MPP ϩ -treated cells. Fig. 1E shows that incubation with 70 M MPP ϩ caused an increase in 55 Fe uptake by cells. These results are consistent with the hypothesis that MPP ϩ -induced iron uptake occurs through an IRP1-regulated, TfR-dependent transport mechanism.
MPP ϩ -induced Intracellular BH 4 Depletion and Inhibition of nNOS Activity and nNOS Dimer Levels in CGNs-We have shown previously that hydrogen peroxide-induced TfR iron uptake is critically dependent on the intracellular ⅐ NO concentration (37) . As BH 4 is one of the crucial regulators of NOS activity, we monitored intracellular BH 4 level in MPP ϩ -treated CGNs. Fig. 2A 55 Fe uptake in CGNs. CGNs were treated with 70 M MPP ϩ for different time periods as indicated, and the total aconitase activity was measured in whole cell lysates (A), the IRP1 activity was analyzed in cytoplasmic extracts by the gel shift assay with and without ␤-mercaptoethanol (1%) (B), TfR protein levels were determined in cell lysates by Western blotting analysis using the antiTfR antibody (C), TfR mRNA levels were determined by the RT-PCR method as time-dependent reduction in intracellular BH 4 levels. After a 24-h incubation, intracellular BH 4 was decreased significantly to ϳ50% of control. Intracellular BH 4 further decreased after a 36-h incubation, and remained at that level after a 48-h incubation with MPP ϩ . Under conditions when BH 4 levels are insufficient, NOS activity decreases as a result of uncoupling of NOS (21) . nNOS activity was monitored by measuring the nitrate/nitrite levels in MPP ϩ -treated cells. Fig. 2B shows that 70 M MPP ϩ treatment for 24 h significantly decreased nitrate/ nitrite formation. To investigate whether the decrease in nitrate/nitrite formation was the result of altered nNOS protein levels, we determined the effect of MPP ϩ on the expression of cellular nNOS protein by Western blotting. BH 4 is crucial for nNOS dimerization, and BH 4 deficiency has been reported to cause a decrease in NOS dimer levels (42) . LT-PAGE was used to examine the effect of MPP ϩ treatment on nNOS dimer formation in CGNs. As shown in Fig. 2 (C and D) , MPP ϩ (70 M) treatment decreased nNOS dimer in a time-dependent manner. However, there was also a decrease in nNOS monomer levels, the reasons for which remain unclear. Nonetheless, as reported in a recent study (51) , it is conceivable that nNOS antibody did not fully recognize the monomer form of nNOS, which could account for decreased nNOS dimer levels without the concomitant increase in the monomer form. These findings show that MPP ϩ treatment decreases the BH 4 levels and ⅐ NO generation in CGNs via decreased stabilization of the dimeric form of nNOS.
Effect of BH 4 Deficiency on MPP ϩ -induced Superoxide Generation in CGNs-We and others have shown previously that nNOS generates superoxide in the absence of BH 4 and that the ratio between ⅐ NO and superoxide is critically regulated by BH 4 levels (21, 52). Intracellular BH 4 levels were manipulated to clarify the role of BH 4 and nNOS in MPP ϩ -induced toxicity in cells. Intracellular BH 4 content was reduced by treating cells with inhibitors of BH 4 de novo synthesis. In agreement with a previous report (53) , Fig. 3 (A and B) shows that inhibiting BH 4 synthesis by incubating cells with DAHP (1 mM) and NAS (100 M) for 24 h caused an increase in superoxide generation in CGNs. We then investigated superoxide generation in MPP ϩ -treated cells. As shown in Fig. 3 (C and D) , treatment of cells with 1 mM DAHP and 50 M MPP ϩ caused a significant increase in superoxide generation, as compared with MPP ϩ or DAHP treatment alone.
Effect of BH 4 Repletion on MPP ϩ -induced ROS Generation and Apoptosis in CGNs-Sepiapterin treatment has been shown to increase intracellular BH 4 levels (28, 54). Intracellular BH 4 concentration in CGNs increased more than 10-fold after incubation with 40 M sepiapterin for 24 h (Table I) . This increase was completely reversed by pretreatment with 100 M sepiapterin reductase inhibitor, NAS. Intracellular BH 4 levels decreased by 50% after treatment of cells with 70 M MPP ϩ for 24 h. In sepiapterin-treated cells, however, BH 4 levels remained much higher even after MPP ϩ treatment. This suggests that MPP ϩ does not inhibit the activity of enzymes (e.g. sepiapterin reductase) involved in the de novo and salvage pathway in BH 4 synthesis. MPP ϩ -induced intracellular ROS formation was assessed in sepiapterin-treated cells. As shown in Fig. 4 (A and B) , there was a significant decrease in superoxide generation by 70 decrease in superoxide formation was negated by co-incubation with 100 M NAS, suggesting that BH 4 formed from sepiapterin, and not sepiapterin per se, was responsible for decreasing MPP ϩ -dependent superoxide formation. Interestingly, pretreatment of CGNs with iron chelators (deferoxamine and HBED) for 2 h significantly inhibited MPP ϩ -induced superoxide formation. This result suggests a causal relationship between intracellular iron and BH 4 levels.
Recently, we reported that the oxidation of DCFH, a nonfluorescent probe, to a fluorescent product, DCF, is dependent on the intracellular H 2 O 2 and redox-active iron (55, 56) . DCF staining in Fig. 4 (C and D) shows that pretreatment of cells with 40 M sepiapterin significantly decreased MPP ϩ -induced increased DCF staining, which was reversed by pretreatment with 100 M NAS. Pretreatment of cells with iron chelators (deferoxamine and HBED) for 2 h greatly inhibited MPP ϩ -induced DCF staining (Fig. 4, C and D) . Based on these observations, we conclude that sepiapterin treatment inhibits MPP ϩ -induced TfR iron accumulation in cells.
If depletion of BH 4 content plays a role in MPP ϩ -induced toxicity, then sepiapterin ought to protect against MPP ϩ -induced apoptosis. Treatment of CGNs with 70 M MPP ϩ increased the fraction of TUNEL-positive CGNs from 6 to 55% (Fig. 5, A and B, a and b) . The fraction of TUNEL-positive nuclei was significantly decreased in cells treated with MPP ϩ and 40 M sepiapterin (Fig. 5, A and B, b and c) . As we reported previously (36) , exposure of CGNs to 70 M MPP ϩ for 24 h increased caspase-3-like protease activity by 3-fold (Fig. 5C ). In the presence of 40 M sepiapterin, MPP ϩ -induced caspase-3-like protease activation was significantly inhibited. After incubating with MPP ϩ for 48 h, the cell viability was assayed by the MTT assay; 70 M MPP ϩ treatment decreased cell viability to 47%, and sepiapterin increased the cell viability from 47 to 80% (Fig. 5D) . The protective effects of sepiapterin in DNA fragmentation, caspase-3 activation, and cell viability were all reversed by pretreatment with 100 M NAS. This further confirms our proposal that BH 4 , derived from sepiapterin, can reverse MPP ϩ -induced toxicity in CGNs.
The Mechanism of BH 4 Depletion in MPP
ϩ -treated CGNs-As data shown in Fig. 4 (A and B) suggest a causal relationship between intracellular iron and BH 4 levels, the effects of cell-permeable iron chelators on intracellular BH 4 levels in MPP ϩ -treated cells were determined. Fig. 6A shows that preincubation of cells with deferoxamine or HBED inhibited BH 4 depletion in MPP ϩ -treated CGNs, indicating that intracellular redox-active iron might play an important role in BH 4 depletion. To examine further the involvement of TfR-dependent iron in BH 4 depletion, the monoclonal (IgA) anti-TfR antibody (42/6) was used to specifically bind to the extracellular domain of the TfR and block receptor endocytosis. In the presence of 42/6, iron can not enter the cell through TfR. shows that the presence of 12 g/ml 42/6 inhibited MPP ϩ -induced BH 4 depletion. These results suggest that MPP ϩ -induced BH 4 depletion likely occurs through a TfR-dependent iron transport mechanism.
The effect of MPP ϩ on BH 4 synthesis was assessed by monitoring the expression of GTPCH I, the rate-limiting enzyme in de novo BH 4 synthesis, in CGNs (Fig. 6, C and D) . GTPCH I mRNA was expressed in CGNs, and the level of expression was not affected by 70 M MPP ϩ treatment up to 36 h (Fig. 6D) . The activity of GTPCH I in MPP ϩ -treated CGNs was then monitored. Fig. 6E shows that 70 M MPP ϩ treatment up to 48 h did not decrease GTPCH I activity.
Effect of BH 4 Repletion on MPP ϩ -induced Changes in nNOS Activity, Aconitase Activity, TfR Protein Expression, and nNOS Dimer Formation-MPP ϩ (70 M) treatment for 24 h decreased the nNOS activity as determined by nitrite levels. Pretreatment with 40 M sepiapterin restored the nNOS activity (Fig.  7A) . Note that sepiapterin treatment itself did not increase nNOS activity, although sepiapterin significantly increased intracellular BH 4 level (Table I) . This suggests that, under normal conditions, nNOS is saturated by endogenous BH 4 . Similarly, pretreatment of CGNs with 40 M sepiapterin inhibited aconitase inactivation caused by 70 M MPP ϩ treatment for 24 h (Fig. 7B) . Concomitantly, MPP ϩ -induced increased cellular TfR protein level was markedly decreased by 40 M sepiapterin pretreatment (Fig. 7, C and D) . The effects of sepiapterin on aconitase activity and TfR protein expression were reversed in the presence of 100 M NAS. These findings suggest that increased intracellular BH 4 levels by sepiapterin down-regulate MPP ϩ -induced TfR expression by inhibiting aconitase inactivation.
We examined the effect of BH 4 supplementation on nNOS dimer formation. Fig. 7 (E and F) shows that MPP ϩ (70 M, 24 h) treatment decreased nNOS dimer, which was reversed by pretreatment of cells with 40 M sepiapterin. Interestingly, sepiapterin treatment itself slightly increased nNOS dimer formation, although we did not investigate this in detail. The iron chelator, HBED, also moderately increased nNOS dimer formation (Fig. 7, G and H) , consistent with its protective effect on BH 4 depletion.
Effect of nNOS Specific Inhibitor on MPP
ϩ -induced Iron Uptake, Apoptosis, and BH 4 Depletion in CGNs-7-Nitroindazole (7-NI) is a specific inhibitor for nNOS and was used to investigate the role of ⅐ NO in MPP ϩ -induced toxicity in CGNs. Fig. 8A shows that treatment of CGNs with the combination of 7-NI (50 M) and MPP ϩ (50 M) significantly increased caspase-3 activity, compared with 7-NI or MPP ϩ alone. Treatment of CGNs with 50 M MPP ϩ slightly decreased the cell viability after 48 h, whereas in the presence of 50 M 7-NI, the percentage of cell death increased from 22 to 78% (Fig. 8B) . The protective effects of sepiapterin on caspase-3 activity and cell viability in MPP ϩ -treated cells were nullified by 7-NI. 7-NI (50 M) itself was toxic to cells after 48 h, and this toxicity was not reversed by pretreatment of cell with 40 M sepiapterin. These findings indicate that the protective effect of sepiapterin is not simply the result of the antioxidant effect of BH 4 . We examined the effect of 7-NI on TfR protein expression in MPP ϩ -treated cells. Fig. 8 (C and D) shows that TfR protein expression was slightly but not significantly increased in the presence of 50 M MPP ϩ or 50 M 7-NI treatment alone, but was significantly increased by combined treatment. The DCF fluorescence analysis showed that co-treatment of cells with 50 M MPP ϩ and 50 M 7-NI for 24 h significantly increased DCF fluorescence when compared with the treatment with MPP ϩ or 7-NI alone (Fig.  8E ). 7-NI treatment counteracted the reduction in both TfR protein level and DCF fluorescence in the presence of sepiapterin.
The effect of 7-NI on MPP ϩ -induced 55 Fe uptake was examined in CGNs. As shown in Fig. 8F , 55 Fe uptake greatly increased in the presence of both 50 M MPP ϩ and 50 M 7-NI, when compared with MPP ϩ or 7-NI alone. These findings suggest that ⅐ NO plays an important role in maintaining the homeostasis of cellular iron levels. The effect of 7-NI on MPP ϩ -induced alterations in intracellular BH 4 was examined. As shown in Fig. 8G , intracellular BH 4 concentration was significantly lower in cells treated with 7-NI (50 M) and 50 M MPP ϩ than in cells treated with either agent alone. These findings indicate a close correspondence between the intracellular iron, BH 4 levels, and ⅐ NO, and that MPP ϩ -induced toxicity in CGNs is governed by all of these factors.
Effect of MPP ϩ on Proteasome Activity in CGNs-We reported previously that oxidative stress decreased both chymotrypsin-like and trypsin-like activities of the 26 S proteasome (37) . Impairment in the proteasome system has been implicated in the pathogenesis of PD (1). Thus, we sought to measure the proteasome activities in MPP ϩ -treated CGNs. Fig. 9 (A and B) shows that 70 M MPP ϩ treatment decreased the trypsin-like and chymotrypsin-like activities in a time-dependent manner. We then investigated the effect of sepiapterin on MPP ϩ -induced changes in proteasome activity. As shown in Fig. 9 (C and D) , 40 M sepiapterin alone significantly increased both trypsin-like and chymotrypsin-like activities in CGNs. The enzyme activities remained elevated in cells during the combined treatment of MPP ϩ and sepiapterin. Although enzyme activities only slightly decreased in the presence of 50 M MPP ϩ or 50 M 7-NI treatment alone, they decreased significantly by both 50 M MPP ϩ and 7-NI treatment. The protective effect of sepiapterin on proteasome activities in MPP ϩ -treated cells is also antagonized by 7-NI treatment (Fig. 9, C  and D) . These data confirm our previous report that ⅐ NO plays an important role in regulating the proteasomal activity (37), indicating that the protective effect of sepiapterin is partially caused by its ability to increase the proteasome activity by increasing BH 4 and nNOS activity and generating more ⅐ NO.
DISCUSSION
In this study, we made the following key observations. (i) MPP ϩ generated mitochondrially derived ROS that stimulated TfR levels and iron signaling. (ii) MPP ϩ -induced H 2 O 2 and Tf-iron were responsible for degrading intracellular BH 4 levels. BH 4 deficiency stimulated nNOS uncoupling, leading to increased superoxide and H 2 O 2 formation and decreased ⅐ NO formation. (iii) Pretreatment with anti-TfR antibody, cell-permeable iron chelators, or sepiapterin to increase intracellular BH 4 all abrogated MPP ϩ -induced oxidative stress and apoptotic cell death. Scheme 1 summarizes the involvement of ROS derived from both mitochondria and nNOS uncoupling mechanism in MPP ϩ -mediated toxicity using CGNs as a cellular model.
Oxidant-induced Iron Signaling-As alluded to in the Introduction, oxidant-induced iron signaling propagates free radical formation in cells. A major portion of cellular iron uptake is utilized for assembly of iron-sulfur clusters and cytochrome synthesis in mitochondria. Inactivation of aconitase stimulates cellular iron signaling mechanisms (47-49). A major pathway by which neuronal cells acquire iron is via TfR, which facilitates the uptake of iron-loaded transferrin (Tf-Fe). The cellular iron sensing mechanism is triggered by iron deficiency or when the 4Fe-4S cluster in aconitase is disassembled in the presence of ROS and RNS (49) . Under conditions of iron deprivation or aconitase inactivation during oxidative stress, the IRPs bind with a high affinity to IRE present on 3Ј-and 5Ј-untranslated regions on TfR and ferritin mRNAs, respectively. The increased binding to TfR mRNA stabilizes the mRNA, leading to enhanced mRNA translation and increased TfR synthesis (49) . As shown in Fig. 1 , CGNs exposed to MPP ϩ elicit an increased TfR synthesis and Tf-Fe uptake via a similar mechanism. Pretreatment of CGNs with anti-TfR antibody inhibited MPP ϩ -induced ROS and apoptosis, supporting a causative role for Tf-Fe in MPP ϩ neurotoxicity (36) . BH 4 Regulates NOS Activity: Uncoupling of NOS-Results indicate that MPP ϩ -induced ROS and Tf-Fe signaling are responsible for the depletion of intracellular BH 4 that was accompanied by a decrease in the nNOS activity and an increase in superoxide formation because of nNOS uncoupling. As shown in Fig. 10, BH 4 , a critical co-factor for NOS activity, acts as a redox switch to the oxygenase domain of NOS (20, 57) . The catalytic domain of nNOS consists of an NADPH-binding reductase, a heme-containing oxygenase domain that binds Larginine, BH 4 , and a calmodulin-binding sequence (57, 58) . In the "resting state," there is no flow of electrons from the reductase to the oxygenase domain. Upon binding of the calciumcalmodulin complex, electrons flow from the reductase domain to the oxygenase domain, resulting in the activation of the enzyme by reducing heme-iron (III) to iron (II) (Fig. 10) . Molecular oxygen binds to the ferrous-heme group, forming the heme-iron (IV)-oxo complex, that oxidizes L-arginine to L-citrulline and ⅐ NO. BH 4 is, however, essential for NOS activation as it stabilizes the oxoferryl state, preventing its disassociation to superoxide. In the presence of BH 4 , there is negligible superoxide formation from NOS.
The present results demonstrate that MPP ϩ treatment causes a time-dependent depletion of BH 4 itory effects of sepiapterin on the various aspects of MPP ϩ toxicity. Thus, the observed protection against MPP ϩ toxicity by sepiapterin is attributed to increased intracellular BH 4 . It is our current hypothesis that this is the result of prevention of NOS uncoupling, resulting in restoration of appropriate NOS activity and inhibition of superoxide-forming oxidase activity.
It has been previously reported that BH 4 stabilizes the functionally active, dimeric form of nNOS (42, 59) . BH 4 also inhibits monomerization of nNOS, as well as the inactivation of the enzyme (60) . We have shown that nNOS monomer generates ROS in lieu of ⅐ NO and L-citrulline in the absence of BH 4 (21) . Furthermore, the ratio between BH 4 and oxidized BH 4 was reported to control the formation of superoxide from endothelial NOS (61) . Exposure of high glucose to bovine aortic endothelial cells was reported to increase the formation of superoxide (51) . Under these conditions, endothelial NOS dimers were decreased (51) . Increased O 2 . formation in bovine aortic endothelial cells treated with high glucose was associated with increased formation of endothelial NOS monomers (51) . Undoubtedly, the cofactor and substrate influence on NOS dimerization, stability, and regulation is more complex, and the degradation of nNOS in a cellular milieu is governed by many regulatory processes including protein-protein interactions and ubiquitin-proteasome pathways (62) (63) (64) (65) . The present work clearly shows that BH 4 depletion in CGNs treated with MPP ϩ was accompanied by a decrease in nNOS homodimer, along with an increase in the nNOS monomer/dimer ratio. Sepiap- 
SCHEME 1. A proposed model for the role of nNOS in MPP
؉ -induced toxicity in CGNs. MPP ϩ -induced ROS inactivates the aconitase enzyme, which in turn increases the levels of non-iron-bound IRP1, enabling it to bind to the 3Ј-untranslated region of TfR mRNA, thereby enhancing its stability and level of expression. Elevation of TfR expression enhances the cellular uptake of iron, decreases BH 4 levels and nNOS dimer form, resulting in more ROS and less ⅐ NO generation by NOS uncoupling, and ultimately results in apoptosis. Increasing intracellular BH 4 levels by sepiapterin treatment lowers MPP ϩ -induced intracellular ROS generation, increases ⅐ NO generation, and prevents the accumulation of TfR-Fe, thereby preventing apoptosis.
terin treatment increased the dimeric form of nNOS in CGNs treated with MPP ϩ . Thus, the protective effect of sepiapterin against MPP ϩ -mediated neurotoxicity is presumably linked to its conversion to BH 4 , which stabilizes the nNOS dimer.
The present data show that cell-permeable iron chelators inhibit MPP ϩ -mediated BH 4 depletion in CGNs (Fig. 4E) . Pretreatment of CGNs with TfR antibody also prevented BH 4 degradation (Fig. 4F) . These findings suggest that Tf-Fe is responsible for BH 4 depletion. Previous reports indicate that both ROS and RNS can react with BH 4 and initiate a free radical chain reaction mechanism forming dihydrobiopterin (two-electron oxidation product) and pterine (four-electron oxidation product) (44) . It is conceivable that a higher oxidant (hydroxyl radical or perferryl iron) formed from intracellular iron and H 2 O 2 is responsible for the depletion of BH 4 in MPP ϩ -treated CGNs.
⅐ NO Controls Iron Homeostasis-The present data show that 7-NI (a selective inhibitor of nNOS) exacerbated MPP ϩ -induced iron uptake, oxidative stress, BH 4 depletion, and apoptosis in CGNs (Fig. 8) . We have recently shown that ⅐ NO regulates oxidant-induced iron signaling, intracellular iron homeostasis, and oxidative stress through increased proteolytic activation (37) . NOS inhibitors decreased the proteasomal activity and enhanced TfR-dependent iron signaling. Nitration of tyrosines present in TfR has been proposed to modulate iron signaling (37) . An increase in protein nitration was detected in the presence of ⅐ NO, H 2 O 2 , and iron (66) . Peroxynitrite formation decreased ⅐ NO levels and enhanced the iron-mediated toxicity while decreasing the proteasomal function. MPP ϩ -mediated neurotoxicity is regulated by Tf-iron signaling that is dependent on intracellular BH 4 .
Implications in Neurodegenerative Diseases-Free radical damage has been implicated in age-related neurodegenerative diseases like PD and Alzheimer's disease (1, 9, 67, 68) , which are marked by a progressive motor dysfunction resulting from selective loss of nigral cells. Iron plays a critical role in initiating and amplifying oxidative damage in tissues (69) . Iron levels are elevated in the substantia nigra of PD patients, and recently Kaur et al. (70) demonstrated that iron chelation by overexpression of the iron binding protein ferritin or by administering an iron chelator (e.g. clioquinol) to mice significantly inhibited MPTP-induced oxidative damage in dopaminergic cells and behavioral deficits. The present results provide new insights into the mechanisms of iron accumulation and ROS formation in CGNs treated with a mitochondrial Parkinsonism-inducing toxin. PD is characterized by impaired nNOS activity and decreased levels of BH 4 and dopamine (2, 15) .
This study reveals an important link between Tf-iron uptake, BH 4 depletion, and enhanced superoxide formation from uncoupled nNOS and demonstrates how nNOS could play a crucial role in eliciting the neuronal apoptosis by MPP ϩ through oxidant-induced iron signaling. Reactive nitrogen species have been implicated in the pathogenesis of age-related neurodegenerative mitochondrial diseases (1, 9) . Recently, we reported that MPP ϩ -induced ␣-synuclein aggregation in neuroblastoma cells might be the result of oxidants generated from H 2 O 2 and TfR-dependent iron (71) . It is likely that the novel molecular mechanism of toxicity proposed here for MPP ϩ and for other mitochondrial neurotoxins, in general, may lead to the development of new neuroprotective strategies for PD and other age-related chronic neurological disorders.
